Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 个订阅源
298 followers
[0] 49 篇文章/周
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Vertex, nearing finish line for non-opioid drug, delves into current difficulties in pain treatment
Pfizer targets broad Talzenna approval in prostate cancer as trial meets patient survival goal
Novartis freed from Swiss antitrust probe over Cosentyx patent strategy
321 followers
[0] 54 篇文章/周
Reporting from the frontiers of health and medicine
618 followers
[0] 80 篇文章/周
Opinion: My four kids and I all have ADHD. We need telehealth options
STAT+: Medical journal peer reviewers are paid millions by industry, study finds
Eli Lilly has an AI chief, telehealth’s DEA troubles, and FDA’s thinking on AI in clinical trials
Morning Rounds: Hospitals’ IV fluid shortage, Bill Nye, and AI skeptics
Contains all the PharmaTimes latest World News.
316 followers
[0] 8 篇文章/周
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
关注The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
493 followers
[0] 13 篇文章/周
BioPharma
311 followers
[0] 26 篇文章/周
Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says
The number of AI medical devices has spiked in the past decade
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
New data underline cancer risk of Bluebird therapy for brain disease
452 followers
[0] 3 篇文章/周
Federal Court Enters Consent Decree Against Rizo Lopez Foods Inc. Following Multistate Outbreak of Listeriosis Linked to Queso Fresco and Cotija Cheese Products
FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities
FDA Roundup: October 4, 2024
FDA Roundup: October 1, 2024
Events
306 followers
[0] 4 篇文章/周
Handling of competing interests: revised rules for committee members and experts
Seizing opportunities in a changing medicines landscape
EMA Management Board: highlights of October 2024 meeting
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024